Arrowhead Pharmaceuticals, Inc. Just Missed Earnings And Its EPS Looked Sad – But Analysts Have Updated Their Models

Shareholders will be ecstatic, with their stake up 34% over the past week following Arrowhead Pharmaceuticals, Inc.'s…